Baker Brothers Advisors - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 133 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$48,802,352
+23.4%
2,809,5770.0%0.28%
+22.7%
Q2 2023$39,558,844
+31.3%
2,809,577
+0.4%
0.23%
+39.6%
Q1 2023$30,123,449
-28.2%
2,799,5770.0%0.16%
-34.9%
Q4 2022$41,937,663
+16.7%
2,799,5770.0%0.25%
+7.2%
Q3 2022$35,947,000
+32.5%
2,799,5770.0%0.24%
+52.6%
Q2 2022$27,128,000
-2.5%
2,799,5770.0%0.15%
-3.8%
Q1 2022$27,828,000
-15.5%
2,799,5770.0%0.16%0.0%
Q4 2021$32,951,000
+3.3%
2,799,5770.0%0.16%
+14.3%
Q3 2021$31,887,000
-18.2%
2,799,5770.0%0.14%
-18.1%
Q2 2021$38,998,000
-24.7%
2,799,5770.0%0.17%
-24.0%
Q1 2021$51,820,000
+4.8%
2,799,5770.0%0.22%
+21.0%
Q4 2020$49,469,000
+15.3%
2,799,5770.0%0.19%
+8.8%
Q3 2020$42,890,000
-39.9%
2,799,5770.0%0.17%
-45.7%
Q2 2020$71,333,000
+64.6%
2,799,5770.0%0.32%
+18.0%
Q1 2020$43,337,000
+40.0%
2,799,5770.0%0.27%
+61.8%
Q4 2019$30,963,000
+30.0%
2,799,5770.0%0.16%
+1.9%
Q3 2019$23,824,000
-37.1%
2,799,5770.0%0.16%
-37.2%
Q2 2019$37,906,000
-30.0%
2,799,577
-6.7%
0.26%
-25.6%
Q1 2019$54,180,000
-35.7%
3,000,0000.0%0.35%
-49.7%
Q4 2018$84,270,000
+10.2%
3,000,0000.0%0.69%
+36.9%
Q3 2018$76,500,000
+47.0%
3,000,0000.0%0.50%
+28.9%
Q2 2018$52,050,0003,000,0000.39%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,474,561$42,983,1255.17%
Rubric Capital Management LP 3,077,449$53,455,2892.00%
Parkman Healthcare Partners LLC 509,810$8,855,4001.62%
TANG CAPITAL MANAGEMENT LLC 600,000$10,422,0001.47%
AlphaCentric Advisors LLC 110,000$1,910,7001.08%
Lion Point Capital, LP 130,691$2,270,1031.01%
RICE HALL JAMES & ASSOCIATES, LLC 650,366$11,296,8570.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 185,853$3,228,2670.53%
ADVISORY RESEARCH INC 204,098$3,545,1820.49%
Jackson Creek Investment Advisors LLC 65,607$1,1400.48%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders